Lan Cao

1.7k total citations
40 papers, 1.2k citations indexed

About

Lan Cao is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Lan Cao has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 10 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Lan Cao's work include Treatment of Major Depression (9 papers), Telomeres, Telomerase, and Senescence (7 papers) and Mental Health Research Topics (7 papers). Lan Cao is often cited by papers focused on Treatment of Major Depression (9 papers), Telomeres, Telomerase, and Senescence (7 papers) and Mental Health Research Topics (7 papers). Lan Cao collaborates with scholars based in China, United States and Australia. Lan Cao's co-authors include Wenbin Wan, Shijin Xia, Bill Kalionis, Xiantao Tai, Zhiguo Wu, Yiru Fang, Wu Hong, Minfeng Chen, Zhenyu Yang and Lin Qi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Lan Cao

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Cao China 20 386 259 190 179 167 40 1.2k
Jennifer R. Cracchiolo United States 20 632 1.6× 261 1.0× 198 1.0× 166 0.9× 286 1.7× 84 2.0k
Nenggui Xu China 18 245 0.6× 206 0.8× 95 0.5× 108 0.6× 204 1.2× 91 1.1k
Jie Ma China 22 125 0.3× 451 1.7× 113 0.6× 178 1.0× 191 1.1× 97 1.3k
Lana S. Rothenburg Canada 10 585 1.5× 239 0.9× 112 0.6× 241 1.3× 481 2.9× 12 1.4k
Norman E. Taylor United States 20 239 0.6× 351 1.4× 307 1.6× 226 1.3× 92 0.6× 33 1.8k
Rena Li United States 13 233 0.6× 256 1.0× 57 0.3× 88 0.5× 126 0.8× 20 1.0k
Sama F. Sleiman United States 17 634 1.6× 785 3.0× 94 0.5× 182 1.0× 168 1.0× 27 1.8k
Shu‐Sheng Jiao China 17 501 1.3× 192 0.7× 68 0.4× 92 0.5× 223 1.3× 24 902
Sigrid Botne Sando Norway 22 649 1.7× 302 1.2× 79 0.4× 62 0.3× 228 1.4× 41 1.3k
Lin Yao China 23 434 1.1× 313 1.2× 64 0.3× 89 0.5× 118 0.7× 56 1.2k

Countries citing papers authored by Lan Cao

Since Specialization
Citations

This map shows the geographic impact of Lan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Cao more than expected).

Fields of papers citing papers by Lan Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Cao. The network helps show where Lan Cao may publish in the future.

Co-authorship network of co-authors of Lan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Cao. A scholar is included among the top collaborators of Lan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Cao. Lan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaohui, Yuncheng Zhu, Zhiguo Wu, et al.. (2022). Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis. Frontiers in Psychiatry. 13. 759334–759334. 6 indexed citations
2.
Zhang, Huifeng, Zhiguo Wu, Lan Cao, et al.. (2021). Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorder. Journal of Affective Disorders. 297. 68–75. 1 indexed citations
3.
Lyu, Dongbin, Zhiguo Wu, Yun Wang, et al.. (2019). Disagreement and factors between symptom on self-report and clinician rating of major depressive disorder: A report of a national survey in China. Journal of Affective Disorders. 253. 141–146. 11 indexed citations
4.
Wan, Wenbin, Lan Cao, Bill Kalionis, et al.. (2019). Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling. Frontiers in Neurology. 10. 607–607. 66 indexed citations
5.
Wu, Zhiguo, Lan Cao, Daihui Peng, et al.. (2018). The clinical correlates of comorbid anxiety symptoms and syndromal anxiety in patients with major depressive disorder. Psychiatry Research. 269. 251–257. 19 indexed citations
6.
Huang, Jia, Yong Wang, Wu Hong, et al.. (2018). The relationship between lifestyle factors and clinical symptoms of bipolar disorder patients in a Chinese population. Psychiatry Research. 266. 97–102. 10 indexed citations
7.
Cao, Lan, Zigao Wang, & Wenbin Wan. (2018). Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease. Frontiers in Neuroscience. 12. 417–417. 32 indexed citations
8.
Li, Zezhi, Zuowei Wang, Chen Zhang, et al.. (2017). Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal study. Psychoneuroendocrinology. 81. 113–121. 27 indexed citations
9.
Hu, Yingyan, Wu Hong, Alicia K. Smith, et al.. (2017). Association analysis between mitogen-activated protein/extracellular signal-regulated kinase (MEK) gene polymorphisms and depressive disorder in the Han Chinese population. Journal of Affective Disorders. 222. 120–125. 6 indexed citations
10.
Li, Zezhi, Qingzhong Wang, Xuemei Wang, et al.. (2017). Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder. PLoS ONE. 12(3). e0172692–e0172692. 9 indexed citations
11.
Wu, Zhiguo, Lan Cao, Haozhe Li, et al.. (2015). Psychiatric comorbidities in patients with major depressive disorder and patients with bipolar II depression in a psychiatric setting. Chin J Psychiatry. 48(5). 266–270. 1 indexed citations
12.
Yuan, Chengmei, Jia Huang, Keming Gao, et al.. (2014). Validation of the Chinese Version of the Short TEMPS-A and its application in patients with mood disorders. Journal of Affective Disorders. 170. 178–184. 13 indexed citations
13.
Weng, Xiaoling, Daizhan Zhou, Fatao Liu, et al.. (2014). DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiation. BMC Neuroscience. 15(1). 31–31. 7 indexed citations
14.
Liu, Yun, Lan Cao, Zhiqiang Li, et al.. (2014). A Genome-Wide Association Study Identifies a Locus on TERT for Mean Telomere Length in Han Chinese. PLoS ONE. 9(1). e85043–e85043. 35 indexed citations
15.
Yang, Zhaoyang, Junyi Ye, Candong Li, et al.. (2013). Drug addiction is associated with leukocyte telomere length. Scientific Reports. 3(1). 1542–1542. 43 indexed citations
16.
Li, Zezhi, Yanxia Zhang, Zuowei Wang, et al.. (2012). The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: Data from multicenter, prospective, longitudinal clinic practice. Journal of Psychiatric Research. 47(1). 8–14. 45 indexed citations
17.
Shen, Qin, Xinzhi Zhao, Lan Yu, et al.. (2012). Association of Leukocyte Telomere Length with Type 2 Diabetes in Mainland Chinese Populations. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1371–1374. 59 indexed citations
18.
Shen, Qin, Zhou Zhang, Lan Yu, et al.. (2011). Common variants near TERC are associated with leukocyte telomere length in the Chinese Han population. European Journal of Human Genetics. 19(6). 721–723. 50 indexed citations
19.
Fang, Yiru, Chengmei Yuan, Yifeng Xu, et al.. (2011). A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression. Journal of Clinical Psychopharmacology. 31(5). 638–642. 47 indexed citations
20.
Fang, Yiru, Chengmei Yuan, Yifeng Xu, et al.. (2010). Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 30(4). 357–364. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer R. Cracchiolo Breakdown of academic impact, for papers by Nenggui Xu Breakdown of academic impact, for papers by Jie Ma Breakdown of academic impact, for papers by Lana S. Rothenburg Breakdown of academic impact, for papers by Norman E. Taylor Breakdown of academic impact, for papers by Rena Li Breakdown of academic impact, for papers by Sama F. Sleiman Breakdown of academic impact, for papers by Shu‐Sheng Jiao Breakdown of academic impact, for papers by Sigrid Botne Sando Breakdown of academic impact, for papers by Lin Yao
Rankless by CCL
2026